On November 3, 2026 Exelixis, Inc. (Nasdaq: EXEL) reported that company management will participate in fireside chats at the following investor conferences in November:

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Guggenheim 3rd Annual Healthcare Innovation Conference: Exelixis is scheduled to present at 9:30 a.m. ET / 6:30 a.m. PT on Tuesday, November 10 in Boston.
Stifel 2026 Healthcare Conference: Exelixis is scheduled to present at 1:20 p.m. ET / 10:20 a.m. PT on Wednesday, November 11 in New York City.
UBS Global Biopharma Conference 2026: Exelixis is scheduled to present at 9:20 a.m. GMT / 4:20 a.m. ET / 1:20 a.m. PT on Tuesday, November 17 in London.
2026 Jefferies Global Healthcare Conference in London: Exelixis is scheduled to present at 1:30 p.m. GMT / 8:30 a.m. ET / 5:30 a.m. PT on Wednesday, November 18 in London.
To access the webcast links, log on to www.exelixis.com and proceed to the Event Calendar page under the Investors & News heading. Replays will also be available at the same location for at least 30 days.

(Press release, Exelixis, NOV 3, 2026, View Source [SID1234674114])